Yan Ming's Form 4 filing
Cytek Biosciences, Inc. (CTKB) · filed Feb 23, 2023
- Accession no.
- 0001209191-23-012359
- Filed
- Feb 23, 2023
- Trade date
- Feb 21, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $218.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yan MingCIK 0001874041 | Director, Officer (Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2023 | Common Stock | MOption exerciseAcquired | +1,981 | – | – | 7,946,825 | Direct | |
| Feb 21, 2023 | Common Stock | FTax withholdingDisposed | −772 | $10.97 | −$8,468.84 | 7,946,053 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −20,000 | $10.94 | −$218,800 | 7,926,053 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2023 | Common Stock | MOption exerciseDisposed | −1,981 | $0.00 | $0 | 23,123 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.